Latest News - Acne

Friday, June 09, 2017 | PracticalDermatology.com

Murad Adds Two New Blemish-busting Products for Acne Awareness Month

June is acne awareness month, and Murad is rolling out two anti-acne new products to help patients say goodbye to blemishes. The new Pore Extractor Pomegranate Mask ($38 from Murad.com) features vo…

Read the full story

Monday, May 15, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Johnson & Johnson, Neutrogena

CVS Pharmacy's New Long Live Skin Campaign Aims to Increase Awareness of Skin Health

CVS Pharmacy, the retail division of CVS Health, is rolling out a new multi-platform Long Live Skin campaign  to increase awareness about skin health, sun safety and proper skincare. The Long …

Read the full story

Wednesday, May 03, 2017 | PracticalDermatology.com, Research and Publications, BioPharmX Corporation, BioPharmX Corporation

BioPharmX Reports Positive Topline Results of BPX-01 Topical Minocycline for Acne

BioPharmX Corporation’s topical minocycline for acne, BPX-01, achieved its primary endpoint in a phase 2b clinical trial. There were statistically significant reductions in non-nodular inflam…

Read the full story

Monday, May 01, 2017 | PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates

Foamix Announces Additional Phase 3 Trial for FMX101 in Moderate to Severe Acne

Foamix Pharmaceuticals is launching an additional Phase 3 trial for FMX101 in moderate to severe acne, a topical minocycline treatment. If the results are positive, this new Phase 3 trial is expect…

Read the full story

Thursday, April 20, 2017 | PracticalDermatology.com, Product Launches and Updates, BioPharmX Corporation

BioPharmX Completes Phase 2b Trial of BPX-01; Topline Results Coming Soon

BioPharmX Corporation completed their last subject visit in a Phase 2b trial of their investigational acne drug, BPX-01, and the last site close-out visit was April 7, 2017. The company now pl…

Read the full story

Tuesday, April 04, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, Novan

Novan Forms New Advisory Council Focused on Nitric Oxide Technologies in Dermatology

Novan, Inc.  has formed an Advisory Council comprised of key opinion leaders with broad expertise in dermatology. These leading physicians will provide medical advice and drug-development insight…

Read the full story

Monday, March 27, 2017 | Phase 3/4 Trials, PracticalDermatology.com, Research and Publications, Allergan

Allergan and Paratek Pharmaceuticals' Acne Drug Performs Well in Phase 3 Trials

Allergan and Paratek Pharmaceuticals, Inc.’s investigational acne drug performed well in two Phase 3 studies, the companies report. Sarecycline, a once-daily, oral, narrow spectrum tetracycli…

Read the full story

Saturday, March 04, 2017 | PracticalDermatology.com, Product Launches and Updates

Cutanea Unveils Aktipak Gel, 3%/5%, Convenient Acne Treatment for "On-the-Go" Patients

Cutanea Life Sciences, Inc. (CLS) introduced Aktipak (erythromycin and benzoyl peroxide) Gel, 3%/5%, a combination therapy indicated for the topical treatment of acne vulgaris. The product is availabl…

Read the full story

Friday, February 03, 2017 | Acquisitions and Mergers, PracticalDermatology.com, PracticalDermatology.com, Suneva, ZO Skin Heath

Breaking Business News: ZO Skin Health, Inc. Acquires Refissa from Suneva Medical

ZO Skin Health, Inc. has acquired the worldwide rights to ReFissa as well as its generic equivalent tretinoin from Suneva Medical. Financial terms for the acquisition were not disclosed. ReFissa is…

Read the full story

Thursday, February 02, 2017 | PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates, Galderma

Galderma’s OTC Differin Gel Hits Store Shelves

Galderma’s Differin Gel 0.1% (adapalene) is now available over the counter (OTC) at major retail and drug stores. Galderma officially launched the gel at a New York City media fete, and …

Read the full story

Friday, January 27, 2017 | Personnel/Company News, Phase 3/4 Trials, PracticalDermatology.com, Research and Publications, Novan

Topline Results from Novan's SB204 Phase 3 Pivotal Trials: Inconsistent Across Trials

Novan, Inc. (NASDAQ:NOVN) today announced  top-line results from the Company’s two, replicate Phase 3 pivotal clinical trials for SB204 in the treatment of acne vulgaris. In the intent-to-t…

Read the full story

Tuesday, January 24, 2017 | PracticalDermatology.com, Sun Pharmaceutical Industries Ltd

Sun Pharma Introduces Leave Acne Behind Patient Initiative

Sun Pharma introudced a new initiative -- “Leave Acne Behind™" -- to educate patients and create awareness of severe recalcitrant nodular acne (SRNA). Sun Pharma reports that out o…

Read the full story

Monday, January 23, 2017 | Personnel/Company News, PracticalDermatology.com, BioPharmX Corporation, BioPharmX Corporation

Specialty Pharma Industry Vet Charles Gregory Vontz Joins BioPharmX Board of Directors

Charles "Greg" Vontz  is joining rhe Board of Directors of BioPharmX Corporation as an independent director, effective as of Jan. 17.  Vontz's appointment expands the board …

Read the full story

Wednesday, January 18, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com

First Patient Treated in Dermata Therapeutics Phase 2 Acne Rosacea Clinical Study

The first patient has been dosed in Dermata Therapeutics’s Phase 2 acne rosacea study of DMT210, a topical gel specifically developed to downregulate the proinflammatory cytokines in the skin re…

Read the full story

Friday, January 13, 2017 | PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates

Actress Bella Thorne Helps Bioré Launch Three New Acne Products

Actress Bella Thorne is the new face of Bioré® Skincare’s trio of acne-fighting charcoal and baking soda products, which are set to launch in early 2017. The new collection include…

Read the full story
Load More